Time To Treatment Augmentation Among Patients With Chronic Obstructive Pulmonary Disease (COPD) Newly Initiated On Long Acting Muscarinic Agents (lama) Or Inhaled Corticosteroid (ics) And Long Acting Beta-2 Agonist (laba) Combination Therapy

被引:0
|
作者
Patel, J. [1 ]
Mapel, D. W. [2 ]
Roberts, M. H. [2 ]
Sama, S. [3 ]
Gilmore, J. [3 ]
Sundaresan, D. [3 ]
Laliberte, F. [4 ]
Pilon, D. [5 ]
Lefebvre, P. [5 ]
Duh, M. [6 ]
机构
[1] GlaxoSmithKline, Res Triangle Pk, NC USA
[2] Lovelace Clin Fdn, Albuquerque, NM USA
[3] Reliant Med Grp, Worcester, MA USA
[4] Grp Anal Ltee, Montreal, PQ, Canada
[5] Grp Anal Ltee, Montreal, PQ, Canada
[6] Anal Grp Inc, Boston, MA USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A5774
引用
收藏
页数:1
相关论文
共 50 条
  • [31] ADDITIONAL EFFECT OF INHALED CORTICO STEROID (ICS) ON PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE RECEIVING LONG-ACTING MUSCARINIC ANTAGONIST(LAMA)/ LONG-ACTING β2-AGONIST(LABA) - SINGLE-CENTRE, PROSPECTIVE, REAL-WORLD STUDY
    Tanaka, Yosuke
    Yajima, Chika
    Hino, Mitsunori
    Saitoh, Yozo
    Nishima, Shunichi
    Kosahira, Seiji
    Motohashi, Norihisa
    Gemma, Akihiko
    RESPIROLOGY, 2017, 22 : 178 - 178
  • [32] Role of Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist Therapy in Chronic Obstructive Pulmonary Disease
    Petite, Sarah E.
    ANNALS OF PHARMACOTHERAPY, 2017, 51 (08) : 696 - 705
  • [33] Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2 - agonists (LABA) for adults with asthma
    Kew, Kayleigh M.
    Evans, David J. W.
    Allison, Debbie E.
    Boyter, Anne C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (06):
  • [34] Assessing the Relationship between Combination Long-Acting Beta Agonist (LABA) and Inhaled Corticosteroid (ICS) Use and Serious Asthma Outcomes
    Wells, Karen E.
    Peterson, Edward L.
    Williams, L. Keoki
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S66 - S66
  • [35] Comparison of pneumonia incidence between long-acting muscarinic antagonist and inhaled corticosteroid plus long-acting beta agonist in patients with COPD
    Lee, Eung Gu
    Kim, Youlim
    Hwang, Yong Il
    Yoo, Kwang Ha
    Lee, So Eun
    Jung, Kyung Yoon
    Lee, Doik
    Park, Yong Bum
    Rhee, Chin Kook
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [36] Comparison of pneumonia incidence between long-acting muscarinic antagonist and inhaled corticosteroid plus long-acting beta agonist in patients with COPD
    Eung Gu Lee
    Youlim Kim
    Yong Il Hwang
    Kwang Ha Yoo
    So Eun Lee
    Kyung Yoon Jung
    Doik Lee
    Yong Bum Park
    Chin Kook Rhee
    Scientific Reports, 13
  • [37] Triple therapy of umeclidinium and inhaled corticosteroid/long-acting β2-agonist (ICS/LABA) vs placebo plus ICS/LABA in GOLD D patients
    Kerwin, Edward
    Siler, Thomas
    Tombs, Lee
    Sousa, Ana R.
    Singletary, Karen
    Church, Alison
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [38] Risk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis
    DiSantostefano, Rachael L.
    Li, Hao
    Hinds, David
    Galkin, Dmitry V.
    Rubin, David B.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2014, 9 : 457 - 468
  • [39] Adherence to Long-Acting Inhaled Therapies among Patients with Chronic Obstructive Pulmonary Disease (COPD)
    Cecere, Laura M.
    Slatore, Christopher G.
    Uman, Jane E.
    Evans, Laura E.
    Udris, Edmunds M.
    Bryson, Chris L.
    Au, David H.
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2012, 9 (03) : 251 - 258
  • [40] COMPARISON OF THREE COMBINATIONS OF INHALED LONG-ACTING MUSCARINIC ANTAGONISTS WITH LONG-ACTING BETA AGONISTS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Mochizuki, Taichi
    Inoue, Yasushi
    Ueda, Ryuta
    Nagase, Seisuke
    Iwasaki, Kentarou
    Kojika, Masakazu
    Hayashi, Aeru
    RESPIROLOGY, 2018, 23 : 247 - 247